All Stories

  1. Translating the Latest 2025 ESC Guidelines and Consensus Statement into Acute Cardiovascular Care Practice

    Article • European Heart Journal Acute Cardiovascular Care, October 2025, Oxford University Press (OUP)

    Dr Julie De Backer

  2. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy

    Article • European Heart Journal, August 2025, Oxford University Press (OUP)

    Dr Julie De Backer

  3. The challenges of decision-making in managing women with prosthetic heart valves during pregnancy: a global concern

    Article • European Heart Journal, July 2025, Oxford University Press (OUP)

    Dr Julie De Backer

  4. Pregnancy outcomes in women with heritable thoracic aortic disease: data from the EORP ESC registry of pregnancy and cardiac disease (ROPAC) III

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, June 2025, Oxford University Press (OUP)

    Dr Julie De Backer

  5. Systematic disruption of zebrafish fibrillin genes identifies a translational zebrafish model for Marfan syndrome

    Article • June 2025, Cold Spring Harbor Laboratory Press

    Dr Julie De Backer

  6. Differences in Arterial Events in Vascular Ehlers-Danlos, Loeys-Dietz, and Marfan Syndrome

    Article • Journal of the American College of Cardiology, June 2025, Elsevier

    Dr Julie De Backer

  7. Editor's Choice – A European Delphi Consensus on the Management of Abdominal Aortic Aneurysms in Patients with Heritable Aortic Diseases

    Article • European Journal of Vascular and Endovascular Surgery, May 2025, Elsevier

    Dr Julie De Backer

  8. Contribution of rare chromosome 22q11.2 copy number variants to non-syndromic bicuspid aortic valve

    Article • Heart, December 2024, BMJ

    Dr Julie De Backer

  9. Assessment of Myocardial Fibrosis in Marfan Syndrome Using Cardiac Magnetic Resonance Imaging

    Article • Molecular Genetics & Genomic Medicine, November 2024, Wiley

    Dr Julie De Backer

  10. Correction: Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations

    Article • European Journal of Human Genetics, September 2024, Springer Science + Business Media

    Dr Julie De Backer

  11. Rare genomic copy number variants implicate new candidate genes for bicuspid aortic valve

    Article • PLOS One, September 2024, PLOS

    Siddharth Prakash, Dr Julie De Backer

  12. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases

    Article • European Heart Journal, August 2024, Oxford University Press (OUP)

    Dr Julie De Backer, Prof. Dr. Christian Heiss

  13. Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations

    Article • European Journal of Human Genetics, July 2024, Springer Science + Business Media

    Dr Julie De Backer

  14. Bicuspid Aortic Valve Disease with Early-Onset Complications: Characteristics and Aortic Outcomes

    Article • Hearts, June 2024, MDPI AG

    Siddharth Prakash, Dr Julie De Backer

  15. Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium

    Article • May 2024, Cold Spring Harbor Laboratory Press

    Dr Julie De Backer

  16. Bicuspid Aortic Valve Disease With Early Onset Complications: Characteristics And Aortic Outcomes

    Article • March 2024, Cold Spring Harbor Laboratory Press

    Dr Julie De Backer

  17. Three-dimensional co-culturing of stem cell-derived cardiomyocytes and cardiac fibroblasts reveals a role for both cell types in Marfan-related cardiomyopathy

    Article • Matrix Biology, February 2024, Elsevier

    Dr Julie De Backer

  18. Biological Age in Congenital Heart Disease—Exploring the Ticking Clock

    Article • Journal of Cardiovascular Development and Disease, December 2023, MDPI AG

    Dr Julie De Backer

  19. Application of an automated analysis framework for pulsed-wave Doppler cardiac ultrasound measurements to generate reference data in adult zebrafish

    Article • AJP Regulatory Integrative and Comparative Physiology, December 2023, American Physiological Society

    Dr Julie De Backer

  20. Rare Genomic Copy Number Variants Implicate New Candidate Genes for Bicuspid Aortic Valve

    Article • October 2023, Cold Spring Harbor Laboratory Press

    Dr Julie De Backer

  21. Refining the course: long-term outcome in patients with bicuspid aortic valve

    Article • European Heart Journal, October 2023, Oxford University Press (OUP)

    Siddharth Prakash, Dr Julie De Backer

  22. Long-term follow-up of atrioventricular valve function in Fontan patients: effect of atrioventricular valve surgery

    Article • European Journal of Cardio-Thoracic Surgery, September 2023, Oxford University Press (OUP)

    Dr Julie De Backer

  23. Shedding light on type B aortic dissection in Marfan syndrome: implications for patient counselling and research priorities

    Article • European Journal of Cardio-Thoracic Surgery, July 2023, Oxford University Press (OUP)

    Dr Julie De Backer

  24. Fluid-Structure Interaction Modeling of the Aortic Hemodynamics in Adult Zebrafish: A Pilot Study Based on Synchrotron X-Ray Tomography

    Article • IEEE Transactions on Biomedical Engineering, July 2023, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Julie De Backer

  25. Preferences for disease-related information and transitional skills among adolescents with congenital heart disease in the early transitional stage

    Article • European Journal of Pediatrics, June 2023, Springer Science + Business Media

    Dr Julie De Backer

  26. Genetic Testing in Patients With Congenital Heart Disease: You Do No Harm When Using the Right Tools!

    Article • Circulation Genomic and Precision Medicine, April 2023, Wolters Kluwer Health

    Dr Julie De Backer

  27. Mitral Annular Disjunction: Associated Pathologies and Clinical Consequences

    Article • Current Cardiology Reports, November 2022, Springer Science + Business Media

    Dr Julie De Backer

  28. Last year of life of adults with congenital heart diseases: causes of death and patterns of care

    Article • European Heart Journal, August 2022, Oxford University Press (OUP)

    Dr Julie De Backer

  29. Hereditary thoracic aortic disease: How to save lives

    Article • Journal of Thoracic and Cardiovascular Surgery, January 2022, Elsevier

    Dr Julie De Backer

  30. Needs and Experiences of Adolescents with Congenital Heart Disease and Parents in the Transitional Process: A Qualitative Study

    Article • Journal of Pediatric Nursing, November 2021, Elsevier

    Dr Julie De Backer

  31. Association of Mitral Annular Disjunction With Cardiovascular Outcomes Among Patients With Marfan Syndrome

    Article • JAMA Cardiology, October 2021, American Medical Association (AMA)

    Dr Julie De Backer

  32. Marfan syndrome

    Article • Nature Reviews Disease Primers, September 2021, Springer Science + Business Media

    Dr Julie De Backer

  33. Influenza Vaccination in Patients With Congenital Heart Disease in the Pre-COVID-19 Era: Coverage Rate, Patient Characteristics, and Outcomes

    Article • Canadian Journal of Cardiology, September 2021, Elsevier

    Dr Julie De Backer

  34. Outflow Through Aortic Side Branches Drives False Lumen Patency in Type B Aortic Dissection

    Article • Frontiers in Cardiovascular Medicine, August 2021, Frontiers

    Dr Julie De Backer

  35. An Overview of Investigational and Experimental Drug Treatment Strategies for Marfan Syndrome

    Article • Journal of Experimental Pharmacology, August 2021, Taylor & Francis

    Dr Julie De Backer

  36. Transition to adulthood and transfer to adult care of adolescents with congenital heart disease: a global consensus statement of the ESC Association of Cardiovascular Nursing and Allied Professions (ACNAP), the ESC Working Group on Adult Congenital Hea...

    Article • European Heart Journal, July 2021, Oxford University Press (OUP)

    Dr Julie De Backer

  37. Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO

    Article • Nature Communications, May 2021, Springer Science + Business Media

    Dr Julie De Backer

  38. QRS Duration During Follow-Up of Tetralogy of Fallot: How Valuable is it? Analysis of ECG Changes in Relation to Pulmonary Valve Implantation

    Article • Pediatric Cardiology, May 2021, Springer Science + Business Media

    Dr Julie De Backer

  39. Guía ESC 2020 para el tratamiento de las cardiopatías congénitas del adulto

    Article • Revista Española de Cardiología, May 2021, Elsevier

    Dr Julie De Backer

  40. Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits

    Article • The European Journal of Health Economics, April 2021, Springer Science + Business Media

    Dr Julie De Backer

  41. Transfer and transition practices in 96 European adult congenital heart disease centres

    Article • International Journal of Cardiology, April 2021, Elsevier

    Dr Julie De Backer

  42. Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease

    Article • Heart, January 2021, BMJ

    Professor Erkin Mirrakhimov, Dr Julie De Backer

  43. Pregnancy Outcomes in Women After Arterial Switch Operation for Transposition of the Great Arteries: Results From ROPAC (Registry of Pregnancy and Cardiac Disease) of the European Society of Cardiology EURObservational Research Programme

    Article • Journal of the American Heart Association, January 2021, Wolters Kluwer Health

    Professor Erkin Mirrakhimov, Dr Julie De Backer

  44. A genotype-first approach to exploring Mendelian cardiovascular traits with clear external manifestations

    Article • Genetics in Medicine, January 2021, Elsevier

    Dr Julie De Backer

  45. Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm

    Article • Genetics in Medicine, January 2021, Elsevier

    Dr Julie De Backer

  46. The Dynamic and Multifaceted Nature of Cardiovascular Disease and Using Genetic Testing to Inform Clinical Care: An International Perspective

    Article • Clinical Chemistry, November 2020, Oxford University Press (OUP)

    Dr Julie De Backer

  47. Genética en la cardiopatía congénita: ¿estamos preparados?

    Article • Revista Española de Cardiología, November 2020, Elsevier

    Dr Julie De Backer

  48. The ESC Clinical Practice Guidelines for the Management of Adult Congenital Heart Disease 2020

    Article • European Heart Journal, October 2020, Oxford University Press (OUP)

    Dr Julie De Backer

  49. The ‘Ten Commandments’ in Adult Congenital Heart Disease Guidelines

    Article • European Heart Journal, October 2020, Oxford University Press (OUP)

    Dr Julie De Backer

  50. Myocardial disease and ventricular arrhythmia in Marfan syndrome: a prospective study

    Article • Orphanet Journal of Rare Diseases, October 2020, Springer Science + Business Media

    Dr Julie De Backer

  51. Effects of fibrillin mutations on the behavior of heart muscle cells in Marfan syndrome

    Article • Scientific Reports, October 2020, Springer Science + Business Media

    Dr Julie De Backer

  52. Creating the BELgian COngenital heart disease database combining administrative and clinical data (BELCODAC): Rationale, design and methodology

    Article • International Journal of Cardiology, October 2020, Elsevier

    Dr Julie De Backer

  53. Myocardial Function, Heart Failure and Arrhythmia in Marfan Syndrome: A Systematic Literature Review

    Article • Diagnostics, September 2020, MDPI AG

    Dr Julie De Backer

  54. Spontaneous Right Ventricular Pseudoaneurysms and Increased Arrhythmogenicity in a Mouse Model of Marfan Syndrome

    Article • International Journal of Molecular Sciences, September 2020, MDPI AG

    Dr Julie De Backer

  55. 2020 ESC Guidelines for the management of adult congenital heart disease

    Article • European Heart Journal, August 2020, Oxford University Press (OUP)

    Dr Julie De Backer

  56. MEK1/2 Inhibition in Murine Heart and Aorta After Oral Administration of Refametinib Supplemented Drinking Water

    Article • Frontiers in Pharmacology, August 2020, Frontiers

    Dr Julie De Backer

  57. Ambulatory Electrocardiographic Monitoring and Ectopic Beat Detection in Conscious Mice

    Article • Sensors, July 2020, MDPI AG

    Dr Julie De Backer

  58. A new dimension in patent foramen ovale size estimation

    Article • Echocardiography, July 2020, Wiley

    Dr Julie De Backer

  59. Pregnancy Outcomes in Women With Cardiovascular Disease: Evolving Trends Over 10 Years in the ESC Registry of Pregnancy and Cardiac Disease (ROPAC)

    Article • Obstetrical & Gynecological Survey, May 2020, Wolters Kluwer Health

    Dr Julie De Backer

  60. Corrosion casting of the cardiovascular structure in adult zebrafish for analysis by scanning electron microscopy and X‐ray microtomography

    Article • Anatomia Histologia Embryologia, January 2020, Wiley

    Dr Julie De Backer

  61. Long-Term Healthcare Utilization, Medical Cost, and Societal Cost in Adult Congenital Heart Disease

    Article • Congenital Heart Disease, January 2020, Computers, Materials and Continua (Tech Science Press)

    Dr Julie De Backer

  62. Features of Marfan syndrome not listed in the Ghent nosology – The Dark Side of the Disease

    Article • Expert Review of Cardiovascular Therapy, December 2019, Taylor & Francis

    Dr Julie De Backer

  63. Angiotensin-II receptor blockade in Marfan syndrome

    Article • The Lancet, December 2019, Elsevier

    Dr Julie De Backer

  64. Case-matched Comparison of Cardiovascular Outcome in Loeys-Dietz Syndrome versus Marfan Syndrome

    Article • Journal of Clinical Medicine, November 2019, MDPI AG

    Dr Julie De Backer

  65. Development of a transition program for adolescents with congenital heart disease

    Article • European Journal of Pediatrics, November 2019, Springer Science + Business Media

    Dr Julie De Backer

  66. European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants

    Article • Orphanet Journal of Rare Diseases, November 2019, Springer Science + Business Media

    Dr Julie De Backer

  67. Genetic testing for aortopathies

    Article • Current Opinion in Cardiology, November 2019, Wolters Kluwer Health

    Dr Julie De Backer

  68. Opinions of general and adult congenital heart disease cardiologists on care for adults with congenital heart disease in Belgium: a qualitative study

    Article • Cardiology in the Young, September 2019, Cambridge University Press

    Dr Julie De Backer

  69. Correction: Arterial tortuosity syndrome: 40 new families and literature review

    Article • Genetics in Medicine, August 2019, Elsevier

    Dr Julie De Backer

  70. Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome

    Article • Molecular Genetics & Genomic Medicine, June 2019, Wiley

    Dr Julie De Backer

  71. Genetic counselling and testing in adults with congenital heart disease: A consensus document of the ESC Working Group of Grown-Up Congenital Heart Disease, the ESC Working Group on Aorta and Peripheral Vascular Disease and the European Society of Huma...

    Article • European Journal of Preventive Cardiology, June 2019, SAGE Publications

    Dr Julie De Backer

  72. Real-world healthcare utilization in adult congenital heart disease: a systematic review of trends and ratios

    Article • Cardiology in the Young, May 2019, Cambridge University Press

    Dr Julie De Backer

  73. Disproportion and dysmorphism in an adult Belgian population with Turner syndrome: risk factors for chronic diseases?

    Article • Acta Clinica Belgica, April 2019, Taylor & Francis

    Dr Julie De Backer, Professor Bert Callewaert, Charlotte Lievens

  74. Staffing, activities, and infrastructure in 96 specialised adult congenital heart disease clinics in Europe

    Article • International Journal of Cardiology, April 2019, Elsevier

    Dr Julie De Backer

  75. Vascular Ehlers-Danlos Syndrome Management

    Article • Journal of the American College of Cardiology, April 2019, Elsevier

    Dr Julie De Backer

  76. SMAD4 rare variants in individuals and families with thoracic aortic aneurysms and dissections

    Article • European Journal of Human Genetics, February 2019, Springer Science + Business Media

    Dr Julie De Backer

  77. Reply

    Article • Journal of the American College of Cardiology, February 2019, Elsevier

    Dr Julie De Backer

  78. Body mass index in adults with congenital heart disease

    Article • Congenital Heart Disease, January 2019, Wiley

    Dr Julie De Backer

  79. SMAD3 pathogenic variants: risk for thoracic aortic disease and associated complications from the Montalcino Aortic Consortium

    Article • Journal of Medical Genetics, January 2019, BMJ

    Dr Julie De Backer

  80. OUP accepted manuscript

    Article • European Heart Journal, January 2019, Oxford University Press (OUP)

    Professor Jolien W Roos-Hesselink, Dr Julie De Backer

  81. Health-Related Quality of Life in Children and Young Adults with Marfan Syndrome

    Article • The Journal of Pediatrics, January 2019, Elsevier

    Dr Julie De Backer

  82. Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association

    Article • Circulation Genomic and Precision Medicine, October 2018, Wolters Kluwer Health

    Dr Julie De Backer

  83. Arterial tortuosity syndrome: 40 new families and literature review

    Article • Genetics in Medicine, October 2018, Elsevier

    Dr Julie De Backer

  84. Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations

    Article • Genetics in Medicine, October 2018, Elsevier

    Dr Julie De Backer

  85. Cardiovascular imaging in Turner syndrome: state-of-the-art practice across the lifespan

    Article • Heart, September 2018, BMJ

    Dr Anthonie L Duijnhouwer, Dr Julie De Backer

  86. Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection

    Article • Journal of the American College of Cardiology, August 2018, Elsevier

    Dr Julie De Backer

  87. Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening

    Article • Pediatric Cardiology, July 2018, Springer Science + Business Media

    Dr Julie De Backer

  88. A heart for fibrillin: spatial arrangement in adult wild-type murine myocardial tissue

    Article • Histochemistry and Cell Biology, June 2018, Springer Science + Business Media

    Dr Julie De Backer

  89. Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome

    Article • Pediatric Cardiology, June 2018, Springer Science + Business Media

    Dr Julie De Backer

  90. Looking for the Missing Links

    Article • Circulation Genomic and Precision Medicine, June 2018, Wolters Kluwer Health

    Dr Julie De Backer

  91. Tailoring the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Guidelines for the Interpretation of Sequenced Variants in the FBN1 Gene for Marfan Syndrome

    Article • Circulation Genomic and Precision Medicine, June 2018, Wolters Kluwer Health

    Dr Julie De Backer

  92. Heart failure and sudden cardiac death in heritable thoracic aortic disease caused by pathogenic variants in the SMAD3 gene

    Article • Molecular Genetics & Genomic Medicine, May 2018, Wiley

    Dr Julie De Backer

  93. Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome

    Article • The American Journal of Cardiology, May 2018, Elsevier

    Dr Julie De Backer

  94. Hungarian Marfan family with large FBN1 deletion calls attention to copy number variation detection in the current NGS era

    Article • Journal of Thoracic Disease, April 2018, AME Publishing Company

    Dr Julie De Backer

  95. Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease

    Article • Circulation, February 2018, Wolters Kluwer Health

    Dr Julie De Backer

  96. Propagation-based phase-contrast synchrotron imaging of aortic dissection in mice: from individual elastic lamella to 3D analysis

    Article • Scientific Reports, February 2018, Springer Science + Business Media

    Dr Julie De Backer

  97. Influence of socioeconomic factors on pregnancy outcome in women with structural heart disease

    Article • Heart, November 2017, BMJ

    Dr Julie De Backer

  98. Organisation of care for pregnancy in patients with congenital heart disease

    Article • Heart, July 2017, BMJ

    Dr Julie De Backer

  99. Sex, pregnancy and aortic disease in Marfan syndrome

    Article • PLOS One, July 2017, PLOS

    Dr Julie De Backer

  100. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

    Article • European Journal of Endocrinology, July 2017, Bioscientifica

    Claus H. Gravholt, Dr Julie De Backer

  101. The spectrum of spontaneous coronary artery dissection: illustrated review of the literature

    Article • Acta Cardiologica, June 2017, Taylor & Francis

    Dr Julie De Backer

  102. Efficacy of losartan as add-on therapy to prevent aortic growth and ventricular dysfunction in patients with Marfan syndrome: a randomized, double-blind clinical trial

    Article • Acta Cardiologica, June 2017, Taylor & Francis

    Dr Julie De Backer

  103. Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC)

    Article • European Heart Journal, May 2017, Oxford University Press (OUP)

    Professor Jolien W Roos-Hesselink, Dr Julie De Backer

  104. The 2017 international classification of the Ehlers-Danlos syndromes

    Article • American Journal of Medical Genetics Part C Seminars in Medical Genetics, March 2017, Wiley

    Dr Julie De Backer, Rodney Grahame

  105. Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome

    Article • American Journal of Medical Genetics Part C Seminars in Medical Genetics, March 2017, Wiley

    Dr Julie De Backer

  106. Pregnancy in Women With SMAD3 Mutation

    Article • Journal of the American College of Cardiology, March 2017, Elsevier

    Dr Julie De Backer

  107. Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome

    Article • Nature Reports Stem Cells, January 2017, Springer Science + Business Media

    Dr Julie De Backer

  108. International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations

    Article • Circulation Cardiovascular Genetics, December 2016, Wolters Kluwer Health

    Dr Julie De Backer

  109. FBN1 : The disease-causing gene for Marfan syndrome and other genetic disorders

    Article • Gene, October 2016, Elsevier

    Dr Julie De Backer

  110. Risk of Pregnancy in Moderate and Severe Aortic Stenosis

    Article • Journal of the American College of Cardiology, October 2016, Elsevier

    Dr Julie De Backer

  111. Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology

    Article • International Journal of Cardiology, October 2016, Elsevier

    Dr Julie De Backer

  112. Long-Term Outcome of Patients with Perimembranous Ventricular Septal Defect: Results from the Belgian Registry on Adult Congenital Heart Disease

    Article • Cardiology, September 2016, Karger Publishers

    Dr Julie De Backer

  113. Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology

    Article • European Journal of Heart Failure, July 2016, Wiley

    Dr Julie De Backer

  114. Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology

    Article • European Journal of Heart Failure, March 2016, Wiley

    Dr Julie De Backer

  115. Mitral valve prolapse syndrome and MASS phenotype: Stability of aortic dilatation but progression of mitral valve prolapse

    Article • IJC Heart & Vasculature, March 2016, Elsevier

    Dr Julie De Backer

  116. Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa

    Article • Revista Española de Cardiología, January 2016, Elsevier

    Konstantinos Dimopoulos, Prof HECTOR BUENO, Dr Julie De Backer

  117. Clinical utility gene card for: Hereditary thoracic aortic aneurysm and dissection including next-generation sequencing-based approaches

    Article • European Journal of Human Genetics, October 2015, Springer Science + Business Media

    Dr Julie De Backer

  118. Type B aortic dissection triggered by heart transplantation in a patient with Marfan syndrome

    Article • BMJ Case Reports, October 2015, BMJ

    Dr Julie De Backer

  119. Genetic Defects in TAPT1 Disrupt Ciliogenesis and Cause a Complex Lethal Osteochondrodysplasia

    Article • The American Journal of Human Genetics, October 2015, Elsevier

    Dr Julie De Backer, Paul Eckhard Witten

  120. Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections

    Article • Current Pharmaceutical Design, September 2015, Bentham Science Publishers

    Dr Julie De Backer

  121. 2015 ESC Guidelines for the management of infective endocarditis

    Article • European Heart Journal, August 2015, European Society of Cardiology

    Prof HECTOR BUENO, Konstantinos Dimopoulos, Dr Julie De Backer

  122. Pregnancy in Women With a Mechanical Heart Valve

    Article • Circulation, July 2015, Wolters Kluwer Health

    Dr Julie De Backer

  123. Intrinsic cardiomyopathy in Marfan syndrome: results from in-vivo and ex-vivo studies of the Fbn1C1039G/+ model and longitudinal findings in humans

    Article • Pediatric Research, June 2015, Nature

    Dr Julie De Backer, Dr Bram Trachet

  124. ClinGen — The Clinical Genome Resource

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2015, New England Journal of Medicine (NEJM/MMS)

    Dr Julie De Backer

  125. Marfan and Sartans: time to wake up!: Figure 1

    Article • European Heart Journal, June 2015, European Society of Cardiology

    Dr Julie De Backer

  126. Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome

    Article • The Application of Clinical Genetics, June 2015, Dove Medical Press

    Dr Julie De Backer

  127. Arterial hypertension in Turner syndrome

    Article • Journal of Hypertension, June 2015, Wolters Kluwer Health

    Dr Julie De Backer

  128. Managing aortic aneurysms and dissections during pregnancy

    Article • Expert Review of Cardiovascular Therapy, May 2015, Taylor & Francis

    Dr Julie De Backer

  129. Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration

    Article • American Heart Journal, May 2015, Elsevier

    Dr Julie De Backer

  130. Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections

    Article • January 2015, Springer Science + Business Media

    Dr Julie De Backer

  131. Gene panel sequencing in heritable thoracic aortic disorders and related entities – results of comprehensive testing in a cohort of 264 patients

    Article • Orphanet Journal of Rare Diseases, January 2015, Springer Science + Business Media

    Dr Julie De Backer

  132. Marfan Syndrome☆

    Article • January 2015, Elsevier

    Dr Julie De Backer

  133. MAT2A Mutations Predispose Individuals to Thoracic Aortic Aneurysms

    Article • The American Journal of Human Genetics, January 2015, Elsevier

    Dr Julie De Backer

  134. The main pulmonary artery in adults: a controlled multicenter study with assessment of echocardiographic reference values, and the frequency of dilatation and aneurysm in Marfan syndrome

    Article • Orphanet Journal of Rare Diseases, December 2014, Springer Science + Business Media

    Dr Julie De Backer

  135. Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2014, New England Journal of Medicine (NEJM/MMS)

    Dr Julie De Backer

  136. A different view on predictors of pulmonary hypertension in secundum atrial septal defect

    Article • International Journal of Cardiology, October 2014, Elsevier

    Dr Julie De Backer

  137. Reference Values for Echocardiographic Assessment of the Diameter of the Aortic Root and Ascending Aorta Spanning All Age Categories

    Article • The American Journal of Cardiology, September 2014, Elsevier

    Dr Julie De Backer

  138. Loeys–Dietz syndrome is a specific phenotype and not a concomitant of any mutation in a gene involved in TGF-β signaling

    Article • Genetics in Medicine, August 2014, Nature

    Dr Julie De Backer

  139. Treatment of pre-existing cardiomyopathy during pregnancy

    Article • Acta Cardiologica, April 2014, Taylor & Francis

    Dr Julie De Backer

  140. Absence of Cardiovascular Manifestations in a Haploinsufficient Tgfbr1 Mouse Model

    Article • PLOS One, February 2014, PLOS

    Dr Julie De Backer, Dr Bram Trachet

  141. Relation between genotype and left-ventricular dilatation in patients with Marfan syndrome

    Article • Gene, January 2014, Elsevier

    Dr Julie De Backer

  142. New insights into the molecular diagnosis and management of heritable thoracic aortic aneurysms and dissections

    Article • Polish Archives of Internal Medicine, December 2013, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Dr Julie De Backer

  143. Heart failure in pregnant women with cardiac disease: data from the ROPAC

    Article • Heart, November 2013, BMJ

    Professor Jolien W Roos-Hesselink, Dr Julie De Backer

  144. First report of the genetic background of Marfan syndrome in Polish patients

    Article • Polish Archives of Internal Medicine, November 2013, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Dr Julie De Backer

  145. Functional analysis of the anatomical right ventricular components: should assessment of right ventricular function after repair of tetralogy of Fallot be refined?

    Article • European Journal of Cardio-Thoracic Surgery, November 2013, Oxford University Press (OUP)

    Dr Julie De Backer

  146. Characterization of Cardiovascular Involvement in Pseudoxanthoma Elasticum Families

    Article • Arteriosclerosis Thrombosis and Vascular Biology, November 2013, Wolters Kluwer Health

    Dr Julie De Backer

  147. Worsening in oxygen saturation and exercise capacity predict adverse outcome in patients with Eisenmenger syndrome

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor Werner Budts, Dr Julie De Backer

  148. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy

    Article • International Journal of Cardiology, September 2013, Elsevier

    Dr Julie De Backer

  149. Genes in Thoracic Aortic Aneurysms and Dissections - Do they Matter?: Translation and Integration of Research and Modern Genetic Techniques into Daily Clinical Practice

    Article • Aorta, July 2013, Science International Corporation

    Dr Julie De Backer

  150. Echocardiographic Methods, Quality Review, and Measurement Accuracy in a Randomized Multicenter Clinical Trial of Marfan Syndrome

    Article • Journal of the American Society of Echocardiography, June 2013, Elsevier

    Dr Julie De Backer

  151. Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy

    Article • American Heart Journal, May 2013, Elsevier

    Dr Julie De Backer

  152. Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD

    Article • International Journal of Cardiology, May 2013, Elsevier

    Dr Julie De Backer

  153. Thoracic aortic-aneurysm and dissection in association with significant mitral valve disease caused by mutations in TGFB2

    Article • International Journal of Cardiology, May 2013, Elsevier

    Dr Julie De Backer

  154. Predictive model for late atrial arrhythmia after closure of an atrial septal defect

    Article • International Journal of Cardiology, April 2013, Elsevier

    Dr Julie De Backer

  155. Aneurysm-osteoarthritis syndrome with visceral and iliac artery aneurysms

    Article • Journal of Vascular Surgery, January 2013, Elsevier

    Professor Jolien W Roos-Hesselink, Dr Julie De Backer

  156. Multiple Aneurysms in a Patient With Aneurysms-Osteoarthritis Syndrome

    Article • The Annals of Thoracic Surgery, January 2013, Elsevier

    Dr Julie De Backer

  157. Twenty patients including 7 probands with autosomal dominant cutis laxa confirm clinical and molecular homogeneity

    Article • Orphanet Journal of Rare Diseases, January 2013, Springer Science + Business Media

    Dr Julie De Backer

  158. In-Frame Mutations in Exon 1 of SKI Cause Dominant Shprintzen-Goldberg Syndrome

    Article • The American Journal of Human Genetics, November 2012, Elsevier

    Dr Julie De Backer

  159. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria

    Article • Human Mutation, July 2012, Wiley

    Dr Julie De Backer

  160. Aggressive Cardiovascular Phenotype of Aneurysms-Osteoarthritis Syndrome Caused by Pathogenic SMAD3 Variants

    Article • Journal of the American College of Cardiology, July 2012, Elsevier

    Professor Jolien W Roos-Hesselink, Dr Julie De Backer

  161. The Ghent Marfan Trial — A randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers

    Article • International Journal of Cardiology, June 2012, Elsevier

    Dr Julie De Backer, Dr Bram Trachet

  162. Right Ventricular Function in Patients With Eisenmenger Syndrome

    Article • The American Journal of Cardiology, April 2012, Elsevier

    Dr Julie De Backer

  163. Questioning the Pathogenic Role of the GLA p.Ala143Thr “Mutation” in Fabry Disease: Implications for Screening Studies and ERT

    Article • JIMD Reports, January 2012, Springer Science + Business Media

    Dr Julie De Backer

  164. Phenotypic spectrum of the SMAD3-related aneurysms–osteoarthritis syndrome

    Article • Journal of Medical Genetics, December 2011, BMJ

    Professor Jolien W Roos-Hesselink, Dr Julie De Backer

  165. The importance of pulmonary artery pressures on late atrial arrhythmia in transcatheter and surgically closed ASD type secundum

    Article • International Journal of Cardiology, October 2011, Elsevier

    Dr Julie De Backer

  166. Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes

    Article • Human Mutation, July 2011, Wiley

    Dr Julie De Backer

  167. A Quantitative Comparison Between Baseline Hemodynamics and End-Stage Aneurysm Formation in ApoE −/− Mice

    Article • June 2011, ASME International

    Dr Julie De Backer, Dr Bram Trachet

  168. The new Ghent criteria for Marfan syndrome: what do they change?

    Article • Clinical Genetics, June 2011, Wiley

    Dr Julie De Backer

  169. An Integrated Framework to Quantitatively Link Mouse-Specific Hemodynamics to Aneurysm Formation in Angiotensin II-infused ApoE −/− mice

    Article • Annals of Biomedical Engineering, May 2011, Springer Science + Business Media

    Dr Julie De Backer, Dr Bram Trachet

  170. Iron deficiency is associated with adverse outcome in Eisenmenger patients

    Article • European Heart Journal, May 2011, European Society of Cardiology

    Dr Julie De Backer

  171. PREDICTING THE OCCURRENCE OF ATRIAL ARRHYTHMIA AFTER CLOSURE OF AN ATRIAL SEPTAL DEFECT

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Dr Julie De Backer

  172. Resolving in-vivo flow fields in the systemic circulation of the mouse through combined ultrasound imaging and computational fluid dynamics

    Article • October 2010, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Julie De Backer, Dr Bram Trachet

  173. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial

    Article • The Lancet, October 2010, Elsevier

    Dr Julie De Backer

  174. Dilated cardiomyopathy caused by a novel TNNT2 mutation—Added value of genetic testing in the correct identification of affected subjects

    Article • International Journal of Cardiology, October 2010, Elsevier

    Dr Julie De Backer

  175. Cardiovascular manifestations in men and women carrying a FBN1 mutation

    Article • European Heart Journal, August 2010, European Society of Cardiology

    Dr Julie De Backer

  176. Short stature, severe aortic root dilation, skin hyperextensibility, extreme joint laxity and craniofacial dysmorphic features: a probable new syndrome

    Article • Clinical Dysmorphology, July 2010, Wolters Kluwer Health

    Dr Julie De Backer

  177. The revised Ghent nosology for the Marfan syndrome

    Article • Journal of Medical Genetics, June 2010, BMJ

    Dr Julie De Backer

  178. Expanding the phenotype of sudden cardiac death—An unusual presentation of a family with a Lamin A/C mutation

    Article • International Journal of Cardiology, January 2010, Elsevier

    Dr Julie De Backer

  179. The Belgian Eisenmenger syndrome registry: Implications for treatment strategies?

    Article • Acta Cardiologica, August 2009, Peeters Publishers

    Dr Julie De Backer

  180. Circulating Transforming Growth Factor-β in Marfan Syndrome

    Article • Circulation, August 2009, Wolters Kluwer Health

    Dr Julie De Backer

  181. Patient-Specific Modelling of Aortic Arch Wall Shear Stress Patterns in Patients With Marfan Syndrome

    Article • June 2009, ASME International

    Dr Julie De Backer, Dr Bram Trachet

  182. Short-term systolic and diastolic ventricular performance after surgical ventricular restoration for dilated ischemic cardiomyopathy

    Article • European Journal of Cardio-Thoracic Surgery, June 2009, Oxford University Press (OUP)

    Dr Julie De Backer

  183. Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: Further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion

    Article • American Journal of Medical Genetics Part A, April 2009, Wiley

    Dr Julie De Backer

  184. Marfan and Marfan-like syndromes

    Article • Artery Research, February 2009, Elsevier

    Dr Julie De Backer

  185. Clinical and Molecular Study of 320 Children With Marfan Syndrome and Related Type I Fibrillinopathies in a Series of 1009 Probands With Pathogenic FBN1 Mutations

    Article • PEDIATRICS, January 2009, American Academy of Pediatrics (AAP)

    Dr Julie De Backer

  186. Strain Rate Imaging Detects Early Cardiac Effects of Pegylated Liposomal Doxorubicin as Adjuvant Therapy in Elderly Patients with Breast Cancer

    Article • Journal of the American Society of Echocardiography, December 2008, Elsevier

    Dr Julie De Backer

  187. Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: Report of 14 novel mutations and review of the literature

    Article • Human Mutation, November 2008, Wiley

    Dr Julie De Backer

  188. Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24–32 mutation

    Article • European Journal of Human Genetics, November 2008, Springer Science + Business Media

    Dr Julie De Backer

  189. The expanding cardiovascular phenotype of Marfan syndrome

    Article • European Journal of Echocardiography, August 2008, European Society of Cardiology

    Dr Julie De Backer

  190. A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patients

    Article • Critical Reviews in Oncology/Hematology, August 2008, Elsevier

    Dr Julie De Backer

  191. Absence of arterial phenotype in mice with homozygous slc2A10 missense substitutions

    Article • genesis, August 2008, Wiley

    Dr Julie De Backer

  192. Effect of an Abdominal Aortic Aneurysm on Wave Reflection in the Aorta

    Article • IEEE Transactions on Biomedical Engineering, May 2008, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Julie De Backer

  193. Successful alcohol septal ablation for late recurrence of left ventricular outflow tract obstruction after surgical myectomy in hypertrophic obstructive cardiomyopathy

    Article • Acta Cardiologica, April 2008, Peeters Publishers

    Dr Julie De Backer

  194. Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands

    Article • Journal of Medical Genetics, January 2008, BMJ

    Dr Julie De Backer

  195. Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families

    Article • Human Mutation, January 2008, Hindawi Publishing Corporation

    Dr Julie De Backer

  196. Effect of Mutation Type and Location on Clinical Outcome in 1,013 Probands with Marfan Syndrome or Related Phenotypes and FBN1 Mutations: An International Study

    Article • The American Journal of Human Genetics, September 2007, Elsevier

    Dr Julie De Backer

  197. Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome

    Article • Clinical Genetics, August 2007, Wiley

    Dr Julie De Backer

  198. The Impact of an Abdominal Aortic Aneurysm on Aortic Wave Reflection

    Article • June 2007, ASME International

    Dr Julie De Backer

  199. Early Surgical Experience With Loeys-Dietz: A New Syndrome of Aggressive Thoracic Aortic Aneurysm Disease

    Article • The Annals of Thoracic Surgery, February 2007, Elsevier

    Dr Julie De Backer

  200. Marfan Syndrome

    Article • January 2007, Elsevier

    Dr Julie De Backer

  201. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood

    Article • Human Mutation, January 2007, Wiley

    Dr Julie De Backer

  202. Experimental and numerical assessment of the impact of abdominal aortic aneurysms on arterial wave reflection

    Article • Computer Methods in Biomechanics & Biomedical Engineering, January 2007, Taylor & Francis

    Dr Julie De Backer

  203. Synergistic inhibition of the enzymatic activity of aminopeptidase N by divalent metal ion chelators

    Article • Fundamental and Clinical Pharmacology, December 2006, Wiley

    Dr Julie De Backer

  204. Primary impairment of left ventricular function in Marfan syndrome

    Article • International Journal of Cardiology, October 2006, Elsevier

    Professor Thierry C Gillebert, Dr Julie De Backer

  205. Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2006, New England Journal of Medicine (NEJM/MMS)

    Dr Julie De Backer

  206. A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome

    Article • Genetics in Medicine, July 2006, Nature

    Dr Julie De Backer

  207. Aortic reflection coefficients and their association with global indexes of wave reflection in healthy controls and patients with Marfan's syndrome

    Article • AJP Heart and Circulatory Physiology, June 2006, American Physiological Society

    Professor Thierry C Gillebert, Dr Julie De Backer

  208. Variability of aortic stiffness is not associated with the fibrillin 1 genotype in patients with Marfan's syndrome

    Article • Heart, May 2006, BMJ

    Dr Julie De Backer

  209. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome

    Article • Nature Genetics, March 2006, Nature

    Dr Julie De Backer

  210. Echocardiographically estimated left ventricular end-diastolic and right ventricular systolic pressure in normotensive healthy individuals

    Article • The International Journal of Cardiovascular Imaging, March 2006, Springer Science + Business Media

    Dr Julie De Backer

  211. The use of Tissue Doppler Imaging for the assessment of changes in myocardial structure and function in inherited cardiomyopathies

    Article • European Journal of Echocardiography, August 2005, European Society of Cardiology

    Professor Thierry C Gillebert, Dr Julie De Backer

  212. Effects of age, gender, and left ventricular mass on septal mitral annulus velocity (E′) and the ratio of transmitral early peak velocity to E′ (E/E′)

    Article • The American Journal of Cardiology, April 2005, Elsevier

    Professor Thierry C Gillebert, Dr Julie De Backer

  213. Evaluation of left ventricular dimensions and function in Marfan's syndrome without significant valvular regurgitation

    Article • The American Journal of Cardiology, March 2005, Elsevier

    Dr Julie De Backer

  214. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

    Article • Nature Genetics, January 2005, Nature

    Dr Julie De Backer

  215. Comprehensive molecular screening of theFBN1gene favors locus homogeneity of classical Marfan syndrome

    Article • Human Mutation, August 2004, Hindawi Publishing Corporation

    Dr Julie De Backer

  216. Functional analysis of the common carotid artery

    Article • Journal of Hypertension, May 2004, Wolters Kluwer Health

    Professor Thierry C Gillebert, Dr Julie De Backer

  217. DUP25 remains unconfirmed

    Article • American Journal of Medical Genetics, January 2004, Wiley

    Dr Julie De Backer

  218. Familiale aandoeningen van de thoracale aorta

    Article • Tijdschrift voor Geneeskunde, January 2004, Peeters Publishers

    Professor Thierry C Gillebert, Dr Julie De Backer

  219. Diastolic dysfunction, infarct size, and exercise capacity in remote myocardial infarction: a combined approach of mitral E-wave deceleration time and color M-mode flow propagation velocity

    Article • The American Journal of Cardiology, March 2002, Elsevier

    Professor Thierry C Gillebert, Dr Julie De Backer

  220. Parameters of inflammation and infection in a community based case-control study of coronary heart disease

    Article • Atherosclerosis, February 2002, Elsevier

    Dr Julie De Backer

  221. QT dispersion is not related to infarct size or inducibility in patients with coronary artery disease and life threatening ventricular arrhythmias

    Article • Heart, May 1999, BMJ

    Dr Julie De Backer

  222. Connective Tissue Disorders

    Article • Wiley

    Dr Julie De Backer